119 related articles for article (PubMed ID: 33617469)
1. 53BP1 expression as a biomarker to differentiate thyroid follicular tumors.
Sato A; Matsuda K; Motoyama T; Mussazhanova Z; Otsubo R; Kondo H; Akazawa Y; Higuchi M; Suzuki A; Hirokawa M; Miyauchi A; Nagayasu T; Nakashima M
Endocr Connect; 2021 Mar; 10(3):309-315. PubMed ID: 33617469
[TBL] [Abstract][Full Text] [Related]
2. A Novel Diagnostic Method for Thyroid Follicular Tumors Based on Immunofluorescence Analysis of p53-Binding Protein 1 Expression: Detection of Genomic Instability.
Otsubo R; Matsuda K; Mussazhanova Z; Sato A; Matsumoto M; Yano H; Oikawa M; Kondo H; Ito M; Miyauchi A; Hirokawa M; Nagayasu T; Nakashima M
Thyroid; 2019 May; 29(5):657-665. PubMed ID: 30929573
[No Abstract] [Full Text] [Related]
3. Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis.
Nakashima M; Suzuki K; Meirmanov S; Naruke Y; Matsuu-Matsuyama M; Shichijo K; Saenko V; Kondo H; Hayashi T; Ito M; Yamashita S; Sekine I
Int J Cancer; 2008 Mar; 122(5):1082-8. PubMed ID: 17985346
[TBL] [Abstract][Full Text] [Related]
4. Alteration of p53-binding protein 1 expression during skin carcinogenesis: association with genomic instability.
Naruke Y; Nakashima M; Suzuki K; Matsuu-Matsuyama M; Shichijo K; Kondo H; Sekine I
Cancer Sci; 2008 May; 99(5):946-51. PubMed ID: 18380789
[TBL] [Abstract][Full Text] [Related]
5. Molecular Pathological Characteristics of Thyroid Follicular-Patterned Tumors Showing Nodule-in-Nodule Appearance with Poorly Differentiated Component.
Ueda M; Matsuda K; Kurohama H; Mussazhanova Z; Sailaubekova Y; Kondo H; Shimizu T; Takada N; Matsuoka Y; Otsubo C; Sato S; Yamashita H; Kawakami A; Nakashima M
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892838
[TBL] [Abstract][Full Text] [Related]
6. Significance of p53-binding protein 1 (53BP1) expression in thyroid papillary microcarcinoma: association with BRAFV600E mutation status.
Mussazhanova Z; Matsuda K; Naruke Y; Mitsutake N; Stanojevic B; Rougounovitch T; Saenko V; Suzuki K; Nishihara E; Hirokawa M; Ito M; Nakashima M
Histopathology; 2013 Nov; 63(5):726-34. PubMed ID: 24004175
[TBL] [Abstract][Full Text] [Related]
7. Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid.
Mussazhanova Z; Akazawa Y; Matsuda K; Shichijo K; Miura S; Otsubo R; Oikawa M; Yoshiura K; Mitsutake N; Rogounovitch T; Saenko V; Kozykenova Z; Zhetpisbaev B; Shabdarbaeva D; Sayakenov N; Amantayev B; Kondo H; Ito M; Nakashima M
Endocr J; 2016 May; 63(5):457-67. PubMed ID: 26935218
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern of p53-binding protein 1 as a new molecular indicator of genomic instability in bladder urothelial carcinoma.
Matsuda K; Kawasaki T; Akazawa Y; Hasegawa Y; Kondo H; Suzuki K; Iseki M; Nakashima M
Sci Rep; 2018 Oct; 8(1):15477. PubMed ID: 30341375
[TBL] [Abstract][Full Text] [Related]
9. Significance of abnormal 53BP1 expression as a novel molecular pathologic parameter of follicular-shaped B-cell lymphoid lesions in human digestive tract.
Luong TMH; Matsuda K; Niino D; Kurohama H; Ito M; Nakashima M
Sci Rep; 2021 Feb; 11(1):3074. PubMed ID: 33542453
[TBL] [Abstract][Full Text] [Related]
10. Significance of p53-Binding Protein 1 Nuclear Foci in Cervical Squamous Intraepithelial Lesions: Association With High-Risk Human Papillomavirus Infection and P16
Kawashita S; Matsuda K; Kondo H; Kitajima Y; Hasegawa Y; Shimada T; Kitajima M; Miura K; Nakashima M; Masuzaki H
Cancer Control; 2020; 27(1):1073274819901170. PubMed ID: 32077330
[TBL] [Abstract][Full Text] [Related]
11. Cytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP.
Nishigami K; Liu Z; Taniguchi E; Koike E; Ozaki T; Mori I; Kakudo K
Endocr J; 2012; 59(6):483-7. PubMed ID: 22484994
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
13. Thyroid tumors of uncertain malignant potential: morphologic and imunohistochemical analysis of 29 cases.
Nechifor-Boila A; Borda A; Sassolas G; Hafdi-Nejjari Z; Cătană R; Borson-Chazot F; Berger N; Decaussin-Petrucci M
Pathol Res Pract; 2015 Apr; 211(4):320-5. PubMed ID: 25595997
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms.
Rossi ED; Bizzarro T; Martini M; Capodimonti S; Sarti D; Cenci T; Bilotta M; Fadda G; Larocca LM
Endocrine; 2016 Dec; 54(3):723-732. PubMed ID: 26818914
[TBL] [Abstract][Full Text] [Related]
15. High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma.
Mu N; Juhlin CC; Tani E; Sofiadis A; Reihnér E; Zedenius J; Larsson C; Nilsson IL
Endocrine; 2018 Aug; 61(2):293-302. PubMed ID: 29796987
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
[TBL] [Abstract][Full Text] [Related]
17. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
Lacoste-Collin L; d'Aure D; Bérard E; Rouquette I; Delisle MB; Courtade-Saïdi M
Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
[TBL] [Abstract][Full Text] [Related]
18. Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma.
Vasko VV; Gaudart J; Allasia C; Savchenko V; Di Cristofaro J; Saji M; Ringel MD; De Micco C
Eur J Endocrinol; 2004 Dec; 151(6):779-86. PubMed ID: 15588246
[TBL] [Abstract][Full Text] [Related]
19. Expression of claudin 1, 4 and 7 in thyroid neoplasms.
Süren D; Yildirim M; Sayiner A; Alikanoğlu AS; Atalay I; Gündüz UR; Kaya V; Gündüz Ş; Oruç MT; Sezer C
Oncol Lett; 2017 May; 13(5):3722-3726. PubMed ID: 28529587
[TBL] [Abstract][Full Text] [Related]
20. Artificial neural network model to distinguish follicular adenoma from follicular carcinoma on fine needle aspiration of thyroid.
Savala R; Dey P; Gupta N
Diagn Cytopathol; 2018 Mar; 46(3):244-249. PubMed ID: 29266871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
